Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time to Freeze: Development of OFF- and OFFON-State Freezing of Gait in Parkinson's Disease.

Movement disorders clinical practice·2026
Same author

Reproductive health considerations for IDH-mutant glioma patients considering IDH inhibitor therapy: A retrospective cohort study.

Neuro-oncology practice·2025
Same author

Lessons Learned From a Delayed-Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease.

Annals of clinical and translational neurology·2025
Same author

Correction: Inhibition of COX2 impairs angiogenesis and causes vascular defects in developing zebrafish embryos.

The International journal of developmental biology·2025
Same author

Exploring the relationship between orthostatic hypotension and gait in people with Parkinson's disease.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025
Same author

Healthy euploid dizygotic twin birth after transfer of nonmosaic aneuploid embryos.

Fertility and sterility·2025

Related Experiment Video

Updated: Mar 31, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K

Screening of potential ligands from the ZINC database with RAC1B using molecular docking and dynamics simulation

Kajal Verma1, Lakshmi Pillai1

  • 1Institute of Sciences, SAGE University, Indore, Madhya Pradesh, India.

Bioinformation
|March 30, 2026
PubMed
Summary

This study screened ZINC database compounds for potential breast cancer drug ligands targeting RAC1B. Five compounds showed optimal binding, offering promising leads for further drug development.

Keywords:
ADMEBreast cancerRAC1Bmolecular dockingmolecular dynamics simulationpharmacophore modelling

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Related Experiment Videos

Last Updated: Mar 31, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.6K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.9K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.5K

Area of Science:

  • Oncology
  • Computational Chemistry
  • Drug Discovery

Background:

  • Breast cancer is the most common cancer diagnosis in women globally.
  • Identifying novel therapeutic targets and drug candidates is crucial for improving patient outcomes.
  • RAC1B is implicated in cancer progression, making it a potential target for drug development.

Purpose of the Study:

  • To screen for potential drug ligands that bind to RAC1B.
  • To identify novel compounds from the ZINC database for breast cancer therapy.

Main Methods:

  • Utilized molecular docking and dynamics simulation analysis.
  • Screened the ZINC database for compounds with optimal binding affinity to RAC1B.

Main Results:

  • Identified five lead compounds (ZINC5277811, ZINC16485670, ZINC20530618, ZINC29990274, ZINC3528881) with optimal binding to RAC1B.
  • These compounds demonstrate significant potential for further investigation.

Conclusions:

  • The identified compounds represent promising candidates for breast cancer drug development targeting RAC1B.
  • Further experimental validation is warranted to confirm the efficacy and safety of these lead compounds.